Table 1 Descriptive statistics by sex and year

N^b

2440 (67.40%)

1180 (32.60%)

***

2066 (68.73%)

940 (31.27%)

***

1845 (69.33%)

816 (30.67%)

***

Age^a

71.67 (10.23)

77.60 (9.05)

***

72.03 (10.13)

77.60 (9.02)

***

72.35 (10.10)

77.92 (9.05)

***

Age groups^b

< 55

184 (7.54%)

28 (2.37%)

***

150 (7.26%)

24 (2.55%)

***

125 (6.78%)

22 (2.70%)

***

≥ 55 < 65

397 (16.27%)

79 (6.69%)

333 (16.12%)

62 (6.60%)

295 (15.99%)

52 (6.37%)

≥ 65 < 75

851 (34.88%)

291 (24.66%)

700 (33.88%)

238 (25.32%)

609 (33.01%)

193 (23.65%)

≥ 75

1008 (41.31%)

782 (66.27%)

883 (42.74%)

616 (65.53%)

816 (44.23%)

549 (67.28%)

BMI groups^b

<  18.5

5 (0.20%)

20 (1.69%)

***

5 (0.24%)

12 (1.28%)

***

3 (0.16%)

8 (0.98%)

***

≥ 18.5 < 25

452 (18.52%)

309 (26.19%)

382 (18.49%)

235 (25.00%)

333 (18.05%)

204 (25.00%)

≥ 25 < 30

1203 (49.30%)

471 (39.92%)

1002 (48.50%)

362 (38.51%)

869 (47.10%)

300 (36.76%)

≥ 30

780 (31.97%)

380 (32.20%)

677 (32.77%)

331 (35.21%)

640 (34.69%)

304 (37.25%)

BIMD 2010 (Q1 least deprived, Q5 most deprived)^b

Quartile 1

471 (19.30%)

211 (17.88%)

398 (19.26%)

164 (17.45%)

356 (19.30%)

144 (17.65%)

Quartile 2

552 (22.62%)

261 (22.12%)

483 (23.38%)

215 (22.87%)

445 (24.12%)

191 (23.41%)

Quartile 3

429 (17.58%)

214 (18.14%)

346 (16.75%)

168 (17.87%)

301 (17.29%)

141 (17.28%)

Quartile 4

433 (17.75%)

229 (19.41%)

363 (17.57%)

187 (19.89%)

319 (17.29%)

159 (19.49%)

Quartile 5

555 (22.75%)

265 (22.46%)

476 (23.04%)

206 (21.91%)

424 (22.98%)

181 (22.18%)

Smoking status^b

Smoker

344 (14.10%)

88 (7.46%)

***

292 (14.13%)

66 (7.02%)

***

254 (13.77%)

60 (7.35%)

***

NYHA^b

0

1216 (49.84%)

509 (43.14%)

***

991 (47.97%)

401 (42.66%)

*

852 (46.18%)

331 (40.56%)

*

1

71 (2.91%)

35 (2.97%)

69 (3.34%)

31 (3.30%)

68 (3.69%)

30 (3.68%)

2

281 (11.52%)

131 (11.10%)

267 (12.92%)

132 (14.04%)

262 (14.20%)

123 (15.07%)

3

446 (18.28%)

226 (19.15%)

397 (19.22%)

183 (19.47%)

381 (20.65%)

172 (21.08%)

4

426 (17.46%)

279 (23.64%)

342 (16.55%)

193 (20.53%)

282 (15.28%)

160 (19.61%)

DMP COPD^b

214 (8.77%)

68 (5.76%)

**

186 (9.00%)

53 (5.64%)

**

157 (8.51%)

43 (5.27%)

**

DMP asthma^b

54 (2.21%)

36 (3.05%)

47 (2.27%)

32 (3.40%)

38 (2.06%)

31 (3.80%)

**

DMP type 1 diabetes^b

7 (0.29%)

5 (0.42%)

5 (0.24%)

5 (0.53%)

4 (0.22%)

4 (0.49%)

DMP type 2 diabetes^b

1048 (42.95%)

564 (47.80%)

**

907 (43.90%)

450 (47.87%)

*

818 (44.34%)

392 (48.04%)

Death in observation period^b

252 (10.33%)

151 (12.80%)

*

145 (7.02%)

79 (8.40%)

113 (6.12%)

62 (7.60%)

HMG assignment per month^a

€479.24 (€652.99)

€505.28 (€552.82]

€757.68 (€768,39)

€786.08 (€656.48)

€580.85 (€717.10)

€555.54 (€539.76)

Days survived in observation period^a

347.10 (60.87)

342.19 (69.79)

*

354.07 (48.19)

351.78 (52.95)

355.31 (45.53)

353.57 (48.04)

Angina pectoris^b

1122 (45.98%)

510 (43.22%)

441 (21.35%)

191 (20.32%)

881 (47.75%)

385 (47.18%)

Peripheral vascular disease^b

2332 (95.57%)

1057 (89.58%)

***

1407 (68.10%)

588 (62.55%)

**

1784 (96.69%)

754 (92.40%)

***

Dyslipidemia^b

2071 (84.88%)

937 (79.41%)

***

1560 (75.51%)

650 (69.15%)

***

1620 (87.80%)

680 (83.33%)

**

Congestive heart failure^b

1385 (56.76%)

758 (64.24%)

***

868 (42.01%)

453 (48.19%)

**

938 (50.84%)

471 (57.72%)

**

Hypertension^b

2341 (95.94%)

1137 (96.36%)

1819 (88.04%)

840 (89.36%)

1780 (96.48%)

790 (96.81%)

Dialysis^b

81 (3.32%)

27 (2.29%)

63 (3.05%)

17 (1.81%)

55 (2.98%)

12 (1.47%)

*

PDC-rate ACE inhibitors^a

72.41% (40.13)

66.96 (42.97)

***

69.16 (42.40)

61.94 (45.57)

***

67.42 (43.88)

60.23 (46.37)

***

PDC-rate β-blockers^a

47.76 (32.30)

48.03 (33.86)

43.40 (33.14)

43.55 (34.22)

42.75 (33.58)

43.64 (35.37)

PDC-rate statins^a

83.69 (32.19)

75.10 (39.70)

***

82.68 (33.53)

73.54 (40.79)

***

80.75 (35.56)

72.40 (41.81)

***

PDC-rate anti-platelet agents^a

46.42 (41.60)

44.65 (41.16)

32.83 (39.99)

31.78 (38.99)

27.02 (37.97)

25.41 (35.51)

Health care expenditures^a

€18,467.68 (€18,775.49)

€16,846.24 (€15,868.08)

**

€5723.61 (€10,33.65)

€5549.28 (€10,266.74)

€5582.88 (€10,598.59)

€5430.74 (€9481.66)